The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Combination of NAT and ELISA in Blood Screening
Author(s): 
Pages: 59-61
Year: Issue:  6
Journal: Journal of Gansu Sciences

Keyword:  NATHBVHIVHCV;
Abstract: 通过对血浆标本的核酸和血清学检测结果进行比较分析,探讨核酸检测(NAT)与酶联免疫吸附试验(ELISA)联合应用在血液筛查中的意义.研究从血浆样本中同时提取HBV、HIV和HCV核酸,采用荧光实时聚合酶链反应(PCR)进行检测,同步进行ELISA检测HBV、HIV和HCV抗原或抗体.在5 184份血浆标本中检测出HBV“窗口期”标本12份,检出率为0.23%;检测出HCV“窗口期”标本3份,检出率为0.058%;未检测出HIV“窗口期”标本.从而得出结论,核酸检测可以有效检测出血浆中的HBV、HIV和HCV的“窗口期”标本.
Related Articles
No related articles found